Transversus Abdominis Plane Block on Postoperative Analgesic Efficacy in Elderly Patients Undergoing Minimally Invasive Gastrointestinal Tumor Surgery

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorChinese PLA General Hospital

About this trial

Elderly patients undergoing minimally invasive gastrointestinal tumor surgery face complex postoperative pain management due to age-related physiological decline and surgical particularities, where traditional opioids are prone to adverse effects. Our study investigates the clinical analgesic efficacy of ultrasound-guided transversus abdominis plane block (TAPB) in these patients, focusing on analgesic quality, delirium incidence, opioid consumption, and postoperative recovery indicators. This evaluation aims to assess its clinical value and safety while providing evidence-based insights for optimizing perioperative analgesia protocols.

Eligibility criteria

Qualifiers

Elderly patients scheduled for elective minimally invasive gastrointestinal tumor surgery under general anesthesia

Age ≥65 years

American Society of Anesthesiologists (ASA) physical status classification ≤III

Body mass index (BMI) 18-30 kg/m²

Disqualifiers

Allergy to anesthetic agents

Preoperative chronic pain or chronic use of opioids/nonsteroidal anti-inflammatory drugs (NSAIDs)

Contraindications to regional blockade:Local infection at puncture site

There is cognitive impairment, which is determined based on Mini Mental State Examination (MMSE) scores below the standard threshold

Trial design

Treatments tested in this trial

  • Transversus Abdominis Plane Block, TAPB

Treatment groups

102 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators